Holen Sie sich die Stockscreener-App
57.23
1.88%
-0.94
Schlusskurs vom Vortag:
$58.17
Offen:
$59.105
24-Stunden-Volumen:
11.93M
Relative Volume:
0.41
Marktkapitalisierung:
$12.46B
Einnahmen:
$1.78B
Nettoeinkommen (Verlust:
$164.40M
KGV:
82.94
EPS:
0.69
Netto-Cashflow:
$236.51M
1W Leistung:
-1.37%
1M Leistung:
+19.43%
6M Leistung:
+93.54%
1J Leistung:
+204.73%
1-Tages-Spanne:
$56.72
$59.99
1-Wochen-Bereich:
$52.51
$60.13
52-Wochen-Spanne:
$17.36
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Firmenname
Hims Hers Health Inc
Sektor
Telefon
415-851-0195
Adresse
2269 CHESTNUT ST, SAN FRANCISCO
Vergleichen Sie HIMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
57.26 | 13.15B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
143.87 | 63.59B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.12 | 45.19B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.25B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 23.18B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.45 | 20.30B | 3.08B | 1.24B | 1.07B | 25.61 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-23 | Herabstufung | Needham | Buy → Hold |
| 2025-06-04 | Bestätigt | Needham | Buy |
| 2025-04-29 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-01-07 | Eingeleitet | BTIG Research | Buy |
| 2024-12-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-08-22 | Eingeleitet | Needham | Buy |
| 2024-08-09 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-04-16 | Herabstufung | Jefferies | Buy → Hold |
| 2024-04-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-02-28 | Hochstufung | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | Imperial Capital | In-line |
| 2023-07-28 | Eingeleitet | TD Cowen | Outperform |
| 2023-04-11 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-02-09 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-08 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-07-15 | Eingeleitet | SVB Leerink | Underperform |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-10 | Eingeleitet | Deutsche Bank | Hold |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-11-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Eingeleitet | BofA Securities | Neutral |
| 2021-05-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Eingeleitet | Truist | Hold |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-03-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Eingeleitet | Citigroup | Neutral |
| 2021-02-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-02-08 | Eingeleitet | Tigress Financial | Buy |
Alle ansehen
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Hims & Hers survey: 94% of customers rate telehealth care equal to in-person - Investing.com India
Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor’s Office - Business Wire
Abel Hall LLC Purchases Shares of 4,993 Hims & Hers Health, Inc. $HIMS - MarketBeat
Is Hims & Hers Health Still Attractive After FDA Scrutiny Over Super Bowl Ad? - Yahoo Finance
Hims & Hers (HIMS) Jumps on Leadership Changes, Global Initiatives - MSN
Hims & Hers Looks To Close $10 ARPU Gap With Product Expansion And Partnerships - Seeking Alpha
Will Hims’ (HIMS) Leadership Shift Reveal New Strengths in Operational Execution? - Yahoo
Best Healthcare Stocks To Keep An Eye OnOctober 4th - MarketBeat
10 Hot Stocks Sparking Buying Frenzy - Insider Monkey
Insider Selling: Hims & Hers Health (NYSE:HIMS) CFO Sells 11,595 Shares of Stock - MarketBeat
Hims & Hers Health (NYSE:HIMS) Trading 5.8% HigherHere's What Happened - MarketBeat
Hims & Hers CFO Okupe sells $669k in shares - Investing.com
Best Healthcare Stocks To Follow NowOctober 7th - MarketBeat
Hims & Hers: Are New Health Products Boosting Stocks? - StocksToTrade
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
UNH vs. LLY vs. HIMS: Which Healthcare Stock Is the Best Pick, According to Analysts? - TipRanks
111 Capital Sells 6,970 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health, Inc. $HIMS Shares Sold by QRG Capital Management Inc. - MarketBeat
Hims & Hers Health Stock (HIMS) Opinions on Recent Price Surge - Quiver Quantitative
Why Hims & Hers Stock Slipped Today - MSN
HIMS Stock Dips Following Executive Transition Announcement - GuruFocus
U.S. Indexes Ended Friday Mixed As Rigetti Computing Led, Hims & Hers Health Lagged - Barron's
$HIMS stock is down 8% today. Here's what we see in our data. - Quiver Quantitative
Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties - Weatherford Democrat
Hims & Hers Expands Health Access Through Subscription Revenue Model - Yahoo Finance
Evaluating Hims & Hers Health (HIMS) Valuation After 39% Share Price Surge in the Past Month - Yahoo Finance
Matauro LLC Invests $446,000 in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health names new COO - Seeking Alpha
Hims & Hers Health Announces COO Transition - TipRanks
Hims & Hers Health says Nader Kabbani to step into advisory role on November 2SEC filing - MarketScreener
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know - The Globe and Mail
Hims & Hers (HIMS) Falls as Key Executives Dispose Shares - MSN
How Novo Nordisk Gave Up Its Weight-Loss Gains - Bloomberg.com
OMCL or HIMS: Which Is the Better Value Stock Right Now? - Yahoo Finance
BofA Securities maintains Underperform rating on Hims and Hers stock - Investing.com
Buy HIMS Stock At $56? - Forbes
Hers Health Inc. stock appeals to dividend seekersJuly 2025 Outlook & Daily Entry Point Alerts - newser.com
The Secret to Finding the Next Amazon Is Hiding in Plain Sight - The Motley Fool
Oluyemi Okupe Sells 85,000 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat
Insider Sell: Soleil Boughton Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus
Wait For A Dip To Buy Hims & Hers Health Stock - Trefis
FDA takes aim at Hims & Hers, weight loss drugs in new advertising blitz - WFMJ.com
Hims & Hers Health, Inc. (HIMS) Laps the Stock Market: Here's Why - Yahoo Finance
Notable Monday Option Activity: HIMS, AMBC, EXE - Nasdaq
Hims & Hers Health Stock Skyrockets amid Weight-Loss Mania – But FDA Scrutiny Looms! - ts2.tech
Top Healthcare Stocks To Follow TodaySeptember 26th - MarketBeat
Healthcare Stocks To Follow TodaySeptember 25th - MarketBeat
Dakota Wealth Management Takes Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Not Nearly Enough People Are Talking About Chewy Stock - The Globe and Mail
Promising Medical Stocks To Keep An Eye OnSeptember 28th - MarketBeat
Top Healthcare Stocks To Add to Your WatchlistSeptember 27th - MarketBeat
Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.11%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):